search
Back to results

Personalized Prevention of Depression in Primary Care

Primary Purpose

Depression

Status
Active
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
e-predictD intervention
Brief psychoeducational intervention
Sponsored by
The Mediterranean Institute for the Advance of Biotechnology and Health Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Depression focused on measuring Depression, Primary Prevention, Primary Health Care, Randomized controlled trial, mHealth, App

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • PHQ-9 <10 at baseline
  • Moderate-high risk of depression (predictD risk algorithm score ≥ 10%)

Exclusion Criteria:

  • Not have a smartphone and internet for personal use
  • Unable to speak Spanish
  • Documented terminal illness
  • Documented cognitive impairment
  • Limiting sensory disorder (e.g. deafness)
  • Documented serious mental illness (psychosis, bipolar, addictions, etc.)

Sites / Locations

  • Juan M. Mendive
  • María Isabel Ballesta Rodríguez
  • Antonina Rodríguez Bayón
  • Juan Á Bellón
  • Emiliano Rodríguez
  • Yolanda López del Hoyo

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

e-predictD intervention

m-Health control

Arm Description

In this arm, patients will receive a personalized intervention to prevent depression based on ICTs, risk predictive algorithms and decision support systems (DSS) for patients and General Practitioners (GPs).

In this arm, patients will continue receiving the usual care from their GPs. In addition, they will use an App with the same appearance as the e-predictD App but it will only send weekly messages about physical and mental health management. This intervention is not personalized and does not include GP training and GP-patient interview.

Outcomes

Primary Outcome Measures

Incidence of major depression measured by the Composite International Diagnostic Interview (CIDI)
Composite International Diagnostic Interview (CIDI) is a structured diagnostic interview that provides current diagnoses of major depression

Secondary Outcome Measures

Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) measures symptoms of depression through 9 items, each of which is scored 0 ('not at all') to 3 ('nearly every day'). Low scores are equivalent to less symptoms of depression, the scale range is 0 to 27 (9 items)
Anxious symptoms measured by the General Anxiety Questionnaire (GAD-7)
The General Anxiety Questionnaire (GAD-7) measures generalized anxiety disorder through 7 items, each of which is scored 0 ('not at all') to 3 ('nearly every day'). Low scores are equivalent to less symptoms of anxiety, the scale range is 0 to 21 (7 items)
Probability of depression (predictD risk algorithm)
Cost-effectiveness and cost-utility

Full Information

First Posted
June 17, 2019
Last Updated
March 1, 2023
Sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Collaborators
Preventive Services and Health Promotion Research Network, Institute of Biomedical Research in Málaga (IBIMA), Andalusian Regional Ministry of Health, European Regional Development Fund (FEDER), University of Malaga
search

1. Study Identification

Unique Protocol Identification Number
NCT03990792
Brief Title
Personalized Prevention of Depression in Primary Care
Official Title
Preventing the Onset of Depression Through a Personalized Intervention Based on ICTs, Risk Prediction Algorithms and Decision Support Systems for Patients and GPs: the e-predictD Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 1, 2020 (Actual)
Primary Completion Date
August 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Mediterranean Institute for the Advance of Biotechnology and Health Research
Collaborators
Preventive Services and Health Promotion Research Network, Institute of Biomedical Research in Málaga (IBIMA), Andalusian Regional Ministry of Health, European Regional Development Fund (FEDER), University of Malaga

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main goal is to design, develop and evaluate a personalized intervention to prevent the onset of depression based on Information and Communications Technology (ICTs), risk predictive algorithms and decision support systems (DSS) for patients and general practitioners (GPs). The specific goals are 1) to design and develop a DSS, called e-predictD-DSS, to elaborate personalized plans to prevent depression; 2) to design and develop an ICT solution that integrates the DSS on the web, a mobile application (App), the risk predictive algorithm, different intervention modules and a monitoring-feedback system; 3) to evaluate the usability and adherence of primary care patients and their GPs with the e-predictD intervention; 4) to evaluate the effectiveness of the e-predictD intervention to reduce the incidence of major depression, depression and anxiety symptoms and the probability of major depression next year; 5) to evaluate the cost-effectiveness and cost-utility of the e-predictD intervention to prevent depression. Methods: This is a randomized controlled trial with allocation by cluster (GPs), simple blind, two parallel arms (e-predictD vs "active m-Health control") and 1 year follow-up including 720 patients (360 in each arm) and 72 GPs (36 in each arm). Patients will be free of major depression at baseline and aged between 18 and 55 years old. Primary outcome will be the incidence of major depression at 12 months measured by CIDI. As secondary outcomes: depressive and anxiety symptomatology measured by PHQ-9 and GAD-7 and the risk probability of depression measured by predictD algorithm, as well as cost-effectiveness and cost-utility. The e-predictD intervention is multi-component and it is based on a DSS that helps the patients to elaborate their own personalized depression prevention plans, which the patient approves, and implements, and the system monitors offering feedback to the patient and to the GPs. It is an e-Health intervention because it is based on a web and m-Health because it is also implemented on the patient's smartphones through an App. In addition, it integrates a risk algorithm of depression, which is already validated (the predictD algorithm). It also includes an initial GP-patient interview and a specific training for the GP. Finally, a map of potentially useful local community resources to prevent depression will be integrated into the DSS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
Depression, Primary Prevention, Primary Health Care, Randomized controlled trial, mHealth, App

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
663 (Actual)

8. Arms, Groups, and Interventions

Arm Title
e-predictD intervention
Arm Type
Experimental
Arm Description
In this arm, patients will receive a personalized intervention to prevent depression based on ICTs, risk predictive algorithms and decision support systems (DSS) for patients and General Practitioners (GPs).
Arm Title
m-Health control
Arm Type
Active Comparator
Arm Description
In this arm, patients will continue receiving the usual care from their GPs. In addition, they will use an App with the same appearance as the e-predictD App but it will only send weekly messages about physical and mental health management. This intervention is not personalized and does not include GP training and GP-patient interview.
Intervention Type
Behavioral
Intervention Name(s)
e-predictD intervention
Intervention Description
The intervention is based on validated risk algorithms to predict depression and includes: 1) Mobile applications as main user's interface; 2) a DSS that helps patients to develop their own personalized plans to prevent (PPP) depression; 3) eight intervention modules (the core of the system) including activities to prevent depression, to be proposed by the DSS and chosen by the patient. The intervention is biopsychosocial and multi-component, including the following modules: physical exercise, improving sleep, expanding relationships, problem solving, improving communication skills, assertiveness training, making decisions and managing thoughts. Patients will implement the recommendations and the tool will monitor these actions, offering feedback to improve their PPP at 3, 6 and 9 months. The intervention also includes an initial and single 15-minute face-to-face GP-patient interview.
Intervention Type
Other
Intervention Name(s)
Brief psychoeducational intervention
Intervention Description
The intervention consists of an App that weekly send brief psychoeducational messages about physical and mental health (depression, anxiety, sleep hygiene, physical activity, etc.)
Primary Outcome Measure Information:
Title
Incidence of major depression measured by the Composite International Diagnostic Interview (CIDI)
Description
Composite International Diagnostic Interview (CIDI) is a structured diagnostic interview that provides current diagnoses of major depression
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9)
Description
The Patient Health Questionnaire-9 (PHQ-9) measures symptoms of depression through 9 items, each of which is scored 0 ('not at all') to 3 ('nearly every day'). Low scores are equivalent to less symptoms of depression, the scale range is 0 to 27 (9 items)
Time Frame
12 months
Title
Anxious symptoms measured by the General Anxiety Questionnaire (GAD-7)
Description
The General Anxiety Questionnaire (GAD-7) measures generalized anxiety disorder through 7 items, each of which is scored 0 ('not at all') to 3 ('nearly every day'). Low scores are equivalent to less symptoms of anxiety, the scale range is 0 to 21 (7 items)
Time Frame
12 months
Title
Probability of depression (predictD risk algorithm)
Time Frame
12 months
Title
Cost-effectiveness and cost-utility
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: PHQ-9 <10 at baseline Moderate-high risk of depression (predictD risk algorithm score ≥ 10%) Exclusion Criteria: Not have a smartphone and internet for personal use Unable to speak Spanish Documented terminal illness Documented cognitive impairment Limiting sensory disorder (e.g. deafness) Documented serious mental illness (psychosis, bipolar, addictions, etc.)
Facility Information:
Facility Name
Juan M. Mendive
City
Barcelona
Country
Spain
Facility Name
María Isabel Ballesta Rodríguez
City
Jaén
Country
Spain
Facility Name
Antonina Rodríguez Bayón
City
Linares
Country
Spain
Facility Name
Juan Á Bellón
City
Málaga
Country
Spain
Facility Name
Emiliano Rodríguez
City
Salamanca
Country
Spain
Facility Name
Yolanda López del Hoyo
City
Zaragoza
Country
Spain

12. IPD Sharing Statement

Learn more about this trial

Personalized Prevention of Depression in Primary Care

We'll reach out to this number within 24 hrs